rxstat › Shortages › Alendronic Acid

Alendronic Acid shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Alendronic Acid products are in shortage in Canada (3 of 20 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jun 30, 2026.
Products affected
3 of 20
In shortage since
Jan 18, 2024
Est. full return
Jun 30, 2026
Reports on file
83
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
MINT-ALENDRONATE
70.0MG · TABLET · MINT PHARMACEUTICALS INC
DIN 02394871 · since Jan 18, 2024, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
ACH-ALENDRONATE
5MG · TABLET · ACCORD HEALTHCARE INC
DIN 02381478 · since Jul 12, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
ACH-ALENDRONATE
10MG · TABLET · ACCORD HEALTHCARE INC
DIN 02381486 · since Apr 12, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Resolved
ALENDRONATE
70MG · TABLET · SANIS HEALTH INC
DIN 02352966 · ended Apr 25, 2026 · Disruption of the manufacture of the drug.
Resolved
ALENDRONATE
70MG · TABLET · SANIS HEALTH INC
DIN 02352966 · ended Apr 25, 2026 · Disruption of the manufacture of the drug.
Resolved
NRA-ALENDRONATE
70MG · TABLET · NORA PHARMA INC
DIN 02523116 · ended May 1, 2026 · Disruption of the manufacture of the drug.
Resolved
ACH-ALENDRONATE
70MG · TABLET · ACCORD HEALTHCARE INC
DIN 02381494 · ended Feb 13, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
SANDOZ ALENDRONATE
70MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02288109 · ended Jan 13, 2025 · Requirements related to complying with good manufacturing practices.
Discontinued
SANDOZ ALENDRONATE
70MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02288109
Resolved
PMS-ALENDRONATE-FC
70MG · TABLET · PHARMASCIENCE INC
DIN 02284006 · ended Nov 26, 2024 · Disruption of the manufacture of the drug.
Resolved
AURO-ALENDRONATE
10MG · TABLET · AURO PHARMA INC
DIN 02388545 · ended Oct 15, 2024 · Demand increase for the drug.
Resolved
AURO-ALENDRONATE
70MG · TABLET · AURO PHARMA INC
DIN 02388553 · ended Jul 16, 2024 · Demand increase for the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Alendronic Acid is currently affected by 3 active shortage reports filed with Health Canada by MINT PHARMACEUTICALS INC, ACCORD HEALTHCARE INC.

The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Alendronic Acid is classified under “DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION” (ATC M05BA).

Recent changes

Common questions

When will Alendronic Acid be back in stock in Canada?

The latest manufacturer estimate is Jun 30, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Alendronic Acid in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (drugs affecting bone structure and mineralization)

Partial shortageAlendronic Acid Vitamin D32 of 8 reported products affectedPartial shortageEtidronate Disodium1 of 2 reported products affectedPartial shortagePamidronate Disodium1 of 7 reported products affectedPartial shortageRisedronate3 of 23 reported products affected · est. return Dec 30, 2022Partial shortageZoledronic Acid2 of 14 reported products affected · est. return Jul 6, 2026DiscontinuedClodronate Disodium0 of 2 reported products affected

All drugs affecting bone structure and mineralization shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.